Fundraising Fox
Wouter Joustra
InvestorGeneral Partner at Forbion · Board director at Navigator Medicines
Amsterdam, Netherlands
Writes $100K – $5M checks · typically $1.5M
Find your path to Wouter
286 people in our graph can introduce you to Wouter.
Each arrow is one introduction. Sign up to fill in the first one.
Ask John Smither to introduce you to Wouter
Ask Riley Novak to introduce you to Wouter
Ask Riley Novak to introduce you to Wouter
Sign up to find every way you can get introduced to Wouter
- Your email: the people you already email who know Wouter
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Wouter
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Wouter Joustra is a General Partner at Forbion, which he joined in 2019, where he works on deal origination, portfolio management, and divestment strategies with a focus on the firm's Growth Opportunities Funds targeting late-stage life sciences companies. He previously served as a Senior Trader and Executive Board member of the life sciences franchise at the investment bank Kempen. He holds an M.Sc. in Business Administration and a B.Sc. in International Business and Management, both from the University of Groningen.
Invests in
Biotech
Board director at Navigator Medicines
Intro paths
In turn, Wouter can intro founders to Navigator Medicines's investors below.
Navigator Medicines's investors · 2
Experience
- Vor BioMember Board of Directors (NASDAQ: VOR)current2025 — present
- Verdiva BioMember Board of Directors & Founding Investorcurrent2025 — present
- Navigator Medicines, Inc.Member Board of Directorscurrent2024 — present
- Beacon TherapeuticsMember Board of Directorscurrent2024 — present
- NewAmsterdam Pharma CorporationMember Board of Directors (NASDAQ: NAMS)current2024 — present
- NewAmsterdam Pharma CorporationBoard Member (Observer) (NASDAQ: NAMS)2021 — 2024
- enGeneMember Board of Directors (NASDAQ: ENGN)current2024 — present
- VectorYMember Board of Directorscurrent2023 — presentAmsterdam, North Holland, Netherlands
- ForbionGeneral Partnercurrent2020 — present
- ForbionFEAC Board Director (NASDAQ now: ENGN)2021 — 2023
- ForbionPartner2019 — 2020The Randstad, Netherlands
- Aiolos BioBoard Member & Founding Investor - Sold to GSK for up to $1.4bn2023 — 2024San Francisco, Californië, Verenigde Staten
- VectivBio AGBoard Member (NASDAQ: VECT) - Sold to Ironwood for $1.2bn2022 — 2023
- Gyroscope TherapeuticsBoard Member - Sold to Novartis for up to $1.5bn2021 — 2022
- Van Lanschot Kempen Investment BankingExecutive Boardmember Life Sciences Franchise2017 — 2019Amsterdam, North Holland, Netherlands
- Van Lanschot Kempen Investment BankingSenior Life Sciences Trader2016 — 2019The Randstad, Netherlands
- Da Vinci DerivativesDerivatives Trader2016Amsterdam
- Kempen & CoTrader2013 — 2016Amsterdam Area, Netherlands
- Kempen & CoEquity Research Analyst2013The Randstad, Netherlands
Deals · 2
Navigator MedicinesBoard seat
via Forbion · filed Sep 2024 · $100M raise
Gyroscope Therapeutics LtdBoard seat
via Forbion · filed Apr 2021 · $148M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Forbion European Acquisition Corp.Gyroscope TherapeuticsNewAmsterdam Pharma N.V.VectivBio
Investor
Beacon TherapeuticsVectorYVerdiva Bio
Sources: the firm's website · SEC Form D filings · curated public sources.
Colleagues at Forbion
Frequently asked questions
- Who is Wouter Joustra?
- Wouter Joustra is a General Partner at Forbion, which he joined in 2019, where he works on deal origination, portfolio management, and divestment strategies with a focus on the firm's Growth Opportunities Funds targeting late-stage life sciences companies. He previously served as a Senior Trader and Executive Board member of the life sciences franchise at the investment bank Kempen. He holds an M.Sc. in Business Administration and a B.Sc. in International Business and Management, both from the University of Groningen.
- Where does Wouter Joustra work?
- Wouter Joustra is General Partner at Forbion and Board director at Navigator Medicines.
- What does Wouter Joustra invest in?
- Wouter Joustra invests in Biotech.
- What check size does Wouter Joustra write?
- Wouter Joustra typically writes checks of $100K – $5M.
- What boards does Wouter Joustra sit on?
- Wouter Joustra holds tracked board seats at Forbion European Acquisition Corp., Gyroscope Therapeutics, Gyroscope Therapeutics Ltd, Navigator Medicines, NewAmsterdam Pharma N.V., VectivBio.
- What companies has Wouter Joustra invested in?
- Investments tracked here include Beacon Therapeutics, Gyroscope Therapeutics Ltd, Navigator Medicines, VectorY, Verdiva Bio.
- Where did Wouter Joustra go to school?
- Wouter Joustra studied at University of Groningen (MSc Business Administration); University of Nebraska at Omaha (BSc Economics); University of Groningen (BSc International Business and Management).
Same school
Also attended University of Groningen200
+ 194 more
Also attended University of Nebraska at Omaha29
+ 23 more
Shared employers
Also worked at Vor Bio8
+ 2 more
